The loss of health status in rheumatoid arthritis and the effect of biologic therapy: a longitudinal observational study

被引:0
作者
Frederick Wolfe
Kaleb Michaud
机构
[1] National Data Bank for Rheumatic Diseases,
来源
Arthritis Research & Therapy | / 12卷
关键词
Rheumatoid Arthritis; Rheumatoid Arthritis Patient; Biologic Therapy; Health Assessment Questionnaire; Certolizumab Pegol;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 273 条
  • [1] Scott DL(2006)Tumor necrosis factor inhibitors for rheumatoid arthritis N Engl J Med 355 704-712
  • [2] Kingsley GH(2004)Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial Lancet 363 675-681
  • [3] Klareskog L(2006)The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment Arthritis Rheum 54 26-37
  • [4] Heijde D van der(2004)Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed Ann Rheum Dis 63 508-516
  • [5] de Jager JP(2004)Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial Arthritis Rheum 50 1400-1411
  • [6] Gough A(2003)Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial Arthritis Rheum 48 35-45
  • [7] Kalden J(1999)Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group Lancet 354 1932-1939
  • [8] Malaise M(2004)Comparison of ultrasonographic assessment of synovitis and joint vascularity with radiographic evaluation in a randomized, placebo-controlled study of infliximab therapy in early rheumatoid arthritis Arthritis Rheum 50 1107-1116
  • [9] Martín Mola E(2008)Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapy Ann Rheum Dis 67 547-554
  • [10] Pavelka K(1992)Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis Ann Rheum Dis 51 177-181